Ikena Oncology, Inc. announced preliminary financial results for December 31, 2023 and a workforce reduction plan, as well as regaining global rights to two programs in collaboration with Bristol Myers Squibb.
AI Assistant
IKENA ONCOLOGY INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.